Aptevo Therapeutics ( NASDAQ: APVO ) filed to sell 13,513,513 shares of common stock. Filing More on Aptevo Therapeutics Aptevo Therapeutics announces $2.75M offering priced at-the-market Seeking Alpha’s Quant Rating on Aptevo Therapeutics Historical earnings data for Aptevo Therapeutics Financial information for Aptevo Therapeutics.
Business